Biotech Says Solomon Isn't Owed $3.7M For AstraZeneca Deal
The British biotech formerly known as Spirogen Ltd. pressed a New York federal judge Wednesday to ditch investment banking advisory firm Peter J. Solomon Co.'s suit seeking fees from the company's...To view the full article, register now.
Already a subscriber? Click here to view full article